Cite
MLA Citation
D. Khanna et al.. “FRI0268 Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from The Open-Label Period of The Fasscinate Trial.” Annals of the rheumatic diseases, vol. 75, n.d., pp. 531–532. http://access.bl.uk/ark:/81055/vdc_100134879114.0x000050